| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 68 |
| 1 | DIAZEPAM | 68 |
| 2 | DIAZEPAM ORAL | 68 |
| 3 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 68 |
| 4 | LISDEXAMFETAMINE DIMESYLATE | 68 |
| 5 | NICOTINE | 68 |
| 6 | NICOTINE POLACRILEX | 68 |
| 7 | NICOTINE POLACRILEX MINI | 68 |
| 8 | NICOTINE POLARILEX | 68 |
| 9 | NALOXONE | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RHO(D) IMMUNE GLOBULIN | 6 | 0.0058 |
| 1 | LISDEXAMFETAMINE DIMESYLATE | 68 | 0.0020 |
| 2 | NICOTINE POLACRILEX | 68 | 0.0018 |
| 3 | NICOTINE | 68 | 0.0017 |
| 4 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 5 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 6 | DIAZEPAM ORAL | 68 | 0.0008 |
| 7 | DIAZEPAM | 68 | 0.0006 |
| 8 | ARIPIPRAZOLE | 68 | 0.0006 |
| 9 | PHENOBARBITAL | 7 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 68 |
| 1 | Benzodiazepine [EPC] | 68 |
| 2 | Cholinergic Nicotinic Agonist [EPC] | 68 |
| 3 | Partial Opioid Agonist [EPC] | 34 |
| 4 | Mood Stabilizer [EPC] | 15 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 6 | Retinoid [EPC] | 3 |
| 7 | Anti-epileptic Agent [EPC] | 2 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 |
| 9 | Vitamin B12 [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinergic Nicotinic Agonist [EPC] | 68 | 0.0011 |
| 1 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 2 | Partial Opioid Agonist [EPC] | 34 | 0.0004 |
| 3 | Atypical Antipsychotic [EPC] | 68 | 0.0002 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Benzodiazepine [EPC] | 68 | 0.0001 |
| 6 | Mood Stabilizer [EPC] | 15 | 0.0001 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 8 | Progesterone [EPC] | 1 | 0.0000 |
| 9 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |